The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: rituximab     Quarter: 2016Q3

Total Records: 1,104     Number of Pages: 56

DRUGNAME PT EventCount
Rituximab Gastroenteritis enteroviral 1
Rituximab Gastrointestinal infection 1
RITUXIMAB Genital herpes simplex 1
Rituximab Genital infection female 1
Rituximab Giardiasis 1
RITUXIMAB Gingivitis 1
RITUXIMAB Glomerulonephritis chronic 1
RITUXIMAB Glucose tolerance impaired 1
Rituximab Gluten sensitivity 1
rituximab Graft versus host disease 1
RITUXIMAB Granulocytes abnormal 1
RITUXIMAB Granulocytopenia 1
Rituximab Haemodynamic instability 1
RITUXIMAB Haemoglobin abnormal 1
RITUXIMAB Haemorrhage intracranial 1
Rituximab Haemorrhagic disorder 1
RITUXIMAB Haemothorax 1
Rituximab Hand-foot-and-mouth disease 1
Rituximab Hemianopia homonymous 1
RITUXIMAB Hepatic atrophy 1

Total Records: 1,104     Number of Pages: 56